Anti-ERLEC1 antibody [EPR13849]

• WB

Supplier Data

Western blot - Anti-ERLEC1 antibody [EPR13849] (AB181166)

All lanes:

Western blot - Anti-ERLEC1 antibody [EPR13849] (ab181166) at 1/10000 dilution

All lanes:

HepG2 lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 55 kDa

false

• WB

Supplier Data

Western blot - Anti-ERLEC1 antibody [EPR13849] (AB181166)

All lanes:

Western blot - Anti-ERLEC1 antibody [EPR13849] (ab181166) at 1/2000 dilution

All lanes:

A375 lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 55 kDa

false

• WB

CiteAb

Western blot - Anti-ERLEC1 antibody [EPR13849] (AB181166)

ERLEC1 western blot using anti-ERLEC1 antibody [EPR13849] ab181166. Publication image and figure legend from Wang, T., Wang, B., et al., 2017, PLoS Pathog, PubMed 28985237.

ab181166 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab181166 please see the product overview.

EV71 targets ERAD at multiple points.(A) Diagram of the key molecules involved in ERAD. (B) RD cells were infected with EV71 (MOI = 10) for the indicated times (hpi : hours post-infection). The cells were then harvested and western blot was performed using the indicated antibodies to detect the indicated ERAD components, EV71 2C, and actin. The ERAD molecules assessed in this study were separated into four categories : substrate recognition, retrotranslocation, ubiquitination, and proteasomal degradation. Asterisks indicate the molecules that were obviously downregulated. (C) Full-size western blots for Herp, Hrd1, VIMP, and UBXD8 described in (B). (D) Quantification of Ubc6e, Herp, Hrd1, VIMP, and UBXD8 in (B). The data are presented as means ± SD of three independent experiments.

false